C

Candel Therapeutics
D

CADL

5.38000
USD
0.19
(3.66%)
Market Open
Volume
1,953
EPS
0
Div Yield
0
P/E
-3
Market Cap
172,616,100
News

Title: Candel Therapeutics

Sector: Healthcare
Industry: Biotechnology
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.